AN2 Therapeutics Inc.

ANTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.09

+$0.04 (+0.79%)

Sep 21, 2026, 2:59 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $181.88M

Enterprise Value $103.49M

Beta -0.99

Average Volume 267.59K

Shares Outstanding (Diluted) 44.76M

Shares Change YoY 48.35%

Institutional Ownership 64.28%

Exchange NASDAQ

ISIN US0373261058

Price Performance

Price Change 1M -15.4%

Price Change 3M -6.5%

Price Change 6M 31.9%

Price Change YTD 354.9%

Price Change 1Y 291.5%

Price Change 3Y -63.0%

Price Change 5Y -67.2%

1M CAGR (ann.) -16.9%

1Y CAGR (ann.) 291.5%

5Y CAGR (ann.) N/A

All-Time CAGR -22.0%

Valuation

PE Ratio -4.72

Forward PE N/A

PEG Ratio -0.33

Forward PEG 0.44

PS Ratio N/A

Forward PS 0.80

PB Ratio 2.40

P/FCF Ratio -5.93

P/Adj. FCF Ratio -5.15

P/OCF Ratio -7.32

EV/Sales N/A

EV/EBIT -2.75

EV/EBITDA -2.75

EV/FCF -3.37

Earnings Yield -21.2%

FCF Yield -16.9%

Adj. FCF Yield -19.4%

Financial Health

Net Cash $78.39M

Total Debt $0

Cash & Short-Term Investments $78.39M

Total Assets $81.68M

Current Ratio 14.32

Quick Ratio 14.32

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 14.10

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -15.1%

Returns

Return on Assets -44.4%

Return on Equity -53.5%

Return on Invested Capital -51.0%

Return on Capital Employed -51.0%

Return on Tangible Assets -44.4%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y 39.1%

EPS CAGR 5Y 17.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y 35.6%

FCF CAGR 5Y 1.2%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 8

EPS Growth Next 3Y 9.0%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $9

Price Target Upside 78.2%

Cash Flow

Operating Cash Flow $-30.68M

Free Cash Flow $-30.68M

Adj. Free Cash Flow $-35.32M

FCF Per Share -$0.69

OCF Per Share -$0.69

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-38.81M

EBITDA $-37.57M

Net Income $-36.28M

EPS (Diluted) -$1.07

Revenue / Employee N/A

Profit / Employee $-1.73M

Employees 21